Omega Diagnostics Gp - Trading Statement

* Reuters is not responsible for the content in this press release.

Thu Apr 10, 2008 2:18am EDT 

RNS Number:0440S
Omega Diagnostics Group PLC
10 April 2008




                          Omega Diagnostics Group PLC
                            ('Omega' or 'the Group)

                                 Trading Update


Omega, the AIM listed medical diagnostics company, announces that trading for
the year ended 31st March 2008 was in line with market expectations with
turnover showing an increase for the year of circa 70% over the previous year
(year ended 31st March 2007: £2.03m).


The increase in turnover follows the acquisition of Genesis Diagnostics Ltd and
Cambridge Nutritional Sciences Ltd in September 2007 which contributed around
68% of the growth, and organic growth of around 2%.


The directors are confident for the prospects of the Group for the new financial
year and the Group will announce its results for the year ended 31st March 2008
during July 2008.


Contacts:


Omega Diagnostics Group PLC             Landsbanki Securities     Parkgreen Communications
                                        (UK) Limited

Andrew Shepherd, Chief Executive        Thilo Hoffmann            Ben Knowles
Kieron Harbinson, Finance Director
                                        Simon Brown
Tel: 01259 763030                       020 7426 9000             Tel: 020 7479 7933
www.omegadiagnostics.com                                          Mob: 07900 346 978
                                                                  ben.knowles@parkgreenmedia.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TSTMGGMDNGNGRZG
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.